Language

News topic

Active ingredient SUMATRIPTAN

Current shortage notices for the active ingredient SUMATRIPTAN, structured by product, country and reporting period.

8 notices

← All shortages

What the SUMATRIPTAN notices indicate for the supply chain

The 8 consolidated notices from Belgium, Czechia are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Sumatriptan Teva 100 mg film-coat. tabl. 12

Active ingredient: Sumatriptan

View notice details →
Belgium

Sumatriptan Teva 50 mg film-coat. tabl. 24

Active ingredient: Sumatriptan

View notice details →
Belgium

Imitrex SC 6 mg inj. sol. s.c. cartr. 2 x 0.5 ml

Active ingredient: Sumatriptan

View notice details →
Belgium

Imitrex SC 6 mg inj. sol. s.c. cartr. 2 x 0.5 ml + 1 x Pen

Active ingredient: Sumatriptan

View notice details →